Loading data
CPSHNasdaq
| Unit: USD | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| Revenue | — | 32.6 m USD | — | 21.12 m USD | — |
| Cost of revenue | — | 27.31 m USD | — | 21.24 m USD | — |
| Gross profit | — | 5.29 m USD | — | -118.64 k USD | — |
| Research and development expense | — | 867.66 k USD | — | — | — |
| Selling, general and administrative expense | — | 4.85 m USD | — | 4.26 m USD | — |
| Operating profit | — | 443.97 k USD | — | -4.38 m USD | — |
| Profit before tax | — | 682.64 k USD | — | -4.09 m USD | — |
| Income tax expense | — | 262.28 k USD | — | -958.5 k USD | — |
| Net income (reported basis) | 420 k USD | 420.35 k USD | -3.14 m USD | -3.14 m USD | 1.37 m USD |
| Basic earnings per share | — | 0.03 USD/share | — | -0.22 USD/share | — |
| Diluted earnings per share | — | 0.03 USD/share | — | -0.22 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.